A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation (Q55043340)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation |
scientific article |
Statements
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation (English)
1 reference
1 reference
Lech Polonski
1 reference
Christian J F Holubarsch
1 reference
Martin Rohrbach
1 reference
Matthias Karrasch
1 reference
Erich Boehm
1 reference
Siegfried Rhein
1 reference
1 August 2007
1 reference
113
1 reference
4
1 reference
205-212
1 reference